Cargando…

XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature

Recent studies demonstrated a dramatically increased risk of leukemia in patients with a rare genetic disorder, Xeroderma Pigmentosum group C (XP-C), characterized by constitutive deficiency of global genome nucleotide excision repair (GG-NER). The genetic mechanisms of non-skin cancers in XP-C pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yurchenko, Andrey A., Padioleau, Ismael, Matkarimov, Bakhyt T., Soulier, Jean, Sarasin, Alain, Nikolaev, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672101/ https://www.ncbi.nlm.nih.gov/pubmed/33203900 http://dx.doi.org/10.1038/s41467-020-19633-9

Ejemplares similares

Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts
por: Nikolaev, Sergey, et al.
Publicado: (2022)

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients
por: Yurchenko, Andrey A., et al.
Publicado: (2023)

The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies
por: Sarasin, Alain
Publicado: (2023)

XPC and POLH/XPV Genes Mutated in a Genetic Cluster of Xeroderma Pigmentosum Patients in Northeast Brazil
por: Castro, Ligia Pereira, et al.
Publicado: (2022)

Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series
por: Yurchenko, Andrey. A., et al.
Publicado: (2023)

A practical guide for mutational signature analysis in hematological malignancies
por: Maura, Francesco, et al.
Publicado: (2019)

Recognition of DNA damage by XPC coincides with disruption of the XPC–RAD23 complex
por: Bergink, Steven, et al.
Publicado: (2012)

Aberrant repair initiated by mismatch-specific thymine-DNA glycosylases provides a mechanism for the mutational bias observed in CpG islands
por: Talhaoui, Ibtissam, et al.
Publicado: (2014)

Author Correction: A practical guide for mutational signature analysis in hematological malignancies
por: Maura, Francesco, et al.
Publicado: (2019)

Novel Frameshift Mutations in XPC Gene Underlie Xeroderma Pigmentosum in Pakistani Families
por: Ijaz, Ambreen, et al.
Publicado: (2021)

Further Evidence of Mutational Heterogeneity of the XPC Gene in Tunisian Families: A Spectrum of Private and Ethnic Specific Mutations
por: Ben Rekaya, Mariem, et al.
Publicado: (2013)

PHF6 Mutations in Hematologic Malignancies
por: Kurzer, Jason H., et al.
Publicado: (2021)

mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
por: Rustad, Even H., et al.
Publicado: (2021)

How history and geography may explain the distribution in the Comorian archipelago of a novel mutation in DNA repair-deficient xeroderma pigmentosum patients
por: Sarasin, Alain, et al.
Publicado: (2019)

Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies
por: Stengel, Anna, et al.
Publicado: (2021)

A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report
por: Doubaj, Yassamine, et al.
Publicado: (2017)

Xeroderma Pigmentosum with Severe Neurological Manifestations/De Sanctis–Cacchione Syndrome and a Novel XPC Mutation
por: Uribe-Bojanini, Esteban, et al.
Publicado: (2017)

Detection of S-HBsAg Mutations in Patients with Hematologic Malignancies
por: Konopleva, Maria V., et al.
Publicado: (2021)

SF3B1 Mutations in Hematological Malignancies
por: Cilloni, Daniela, et al.
Publicado: (2022)

A Novel ssDNA Aptamer Targeting Carcinoembryonic Antigen: Selection and Characterization
por: Yunussova, Nigara, et al.
Publicado: (2022)

Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies
por: Nasrallah, Nawar Al, et al.
Publicado: (2022)

Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation
por: Matta, Elie, et al.
Publicado: (2020)

Mutational signatures of ionizing radiation in second malignancies
por: Behjati, Sam, et al.
Publicado: (2016)

Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies
por: Saini, Sunil Kumar, et al.
Publicado: (2022)

Xeroderma Pigmentosum C (XPC) Mutations in Primary Fibroblasts Impair Base Excision Repair Pathway and Increase Oxidative DNA Damage
por: Fayyad, Nour, et al.
Publicado: (2020)

A Novel Case of Gorlin Syndrome Mosaicism Involving an SMO Gene Mutation: Clinical, Histological and Molecular Analysis of Basaloid Tumours
por: IGHILAHRIZ, Meriem, et al.
Publicado: (2021)

DNA-Histone Cross-Links: Formation and Repair
por: Pachva, Manideep C., et al.
Publicado: (2020)

Trajectory and uniqueness of mutational signatures in yeast mutators
por: Loeillet, Sophie, et al.
Publicado: (2020)

The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies
por: Yokota, Asumi, et al.
Publicado: (2020)

TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
por: Alkhatabi, Heba, et al.
Publicado: (2022)

Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies
por: Saitta, Claudia, et al.
Publicado: (2022)

Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family
por: Ali, Muhammad Z., et al.
Publicado: (2020)

A Human XPC Protein Interactome—A Resource
por: Lubin, Abigail, et al.
Publicado: (2013)

The Distribution and Phenotypes of Blood Groups in Hematologic Malignancies
por: Erdemir, Mete, et al.
Publicado: (2023)

Is there an advantageous arrangement of aromatic residues in proteins? Statistical analysis of aromatic interactions in globular proteins
por: Lobanov, Mikhail Yu., et al.
Publicado: (2021)

U2AF1 mutations alter splice site recognition in hematological malignancies
por: Ilagan, Janine O., et al.
Publicado: (2015)

Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies
por: Acuna-Hidalgo, Rocio, et al.
Publicado: (2017)

Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies
por: Ilkovski, Biljana, et al.
Publicado: (2015)

The “Aneuploidy–Modified Mutator-Phenotype” Theory of Malignant Tumors
por: Bignold, Leon P.
Publicado: (2008)

Role of CBL Mutations in Cancer and Non-Malignant Phenotype
por: Leardini, Davide, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ro4vp04bosfa404c26fmn7ae0b